@article{3186897,
    title = "Elotuzumab, Pomalidomide, and Dexamethasone for Relapsed/Refractory
Multiple Myeloma: Efficacy After Additional Follow-Up of the ELOQUENT-3
Study",
    author = "Dimopoulos, Meletios A. and Dytfeld, Dominik and Grosicki, Sebastian and and Moreau, Philippe and Takezako, Naoki and Hori, Mitsuo and Leleu, Xavier and and LeBlanc, Richard and Suzuki, Kenshi and Raab, Marc S. and and Richardson, Paul G. and McKiver, Mihaela Popa and Jou, Ying-Ming and and Shelat, Suresh G. and Robbins, Michael and Rafferty, Brian and and San-Miguel, Jesus",
    journal = "Clinical Lymphoma Myeloma & Leukemia",
    year = "2019",
    volume = "19",
    number = "10, S",
    pages = "E164-E165",
    publisher = "CIG MEDIA GROUP, LP",
    issn = "2152-2650, 2152-2669",
    doi = "10.1016/j.clml.2019.09.275",
    keywords = "elotuzumab; Pomalidomide; Relapsed/Refractory"
}